Baxter is scheduled to announce its second-quarter 2026 earnings results on Thursday, July 30th, before market open. The consensus earnings per share estimate stands at $0.37, representing a 37.3% decline year-over-year, while the consensus revenue estimate is $2.8 billion, down 0.4% from the prior year. Over the past two years, Baxter has beaten EPS estimates 63% of the time and revenue estimates 63% of the time. In the last three months, EPS estimates have seen zero upward revisions and ten downward revisions, while revenue estimates have seen two upward revisions and seven downward revisions.
Baxter International IncEarnings preview with consensus EPS down 37% and revenue down 0.4%, plus downward estimate revisions, but no actual results yet.